WLTW Willis Towers Watson Public Limited Company

Global health care benefit cost increases will vary widely in 2020, says Willis Towers Watson

Global health care benefit cost increases will vary widely in 2020, says Willis Towers Watson

Mental health conditions will be a significant cost factor over the next five years, according to new research

ARLINGTON, Va., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Employer-sponsored health care benefit cost increases are expected to vary widely around the globe in 2020, according to a survey of medical insurers by Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company. The survey found mental health conditions are expected to become one of the most significant cost factors over the next five years.   

, the largest of its kind, found medical insurers globally are projecting health care benefit costs to continue to rise across the world in 2020. Average increases in the five regions will range from 4.3% in Europe to 11.7% in Latin America. 



The study also found that 40% of all respondents expect medical costs will continue to increase at a higher rate over the next three years. Asia Pacific insurers are the most optimistic, with 32% agreeing there will be a moderate increase over the next three years, while 12% believe costs will be lower. Conversely, more than half (54%) of Middle East and Africa insurers believe medical expenses will increase, and virtually none anticipate lower costs.

Global medical trends: Health care benefit cost growth, 2018 – 2020

 201820192020* 
Global+6.5%6.7%6.8% 
United States**8.7%7.9%7.2% 
Latin America+11.6%12.2%11.7% 
Asia Pacific 6.8%7.1%7.1% 
Europe 4.3%4.2%4.3% 
Middle East/Africa 7.9%8.5%9.3% 

*Projected

**U.S. data are from various years of the Willis Towers Watson National Trend Survey.

+Due to the hyperinflationary nature of the Venezuelan economy, Venezuela has been excluded from Latin America regional and global totals. Including Venezuela, the 2020 global average trends would be 7.2%, and Latin American average trends would be 14.8%.

“Controlling rising health care benefit costs remains a top priority for medical insurers and employers globally,” said Cecil Hemingway, managing director and global co-head of Health and Benefits, Willis Towers Watson. “Despite the regional variation, cost increases continue to outpace inflation and remain unsustainable, making affordability a challenge for employers and employees alike. Employers that take steps now to understand the factors driving up costs and evaluate how they deliver health care benefits will be better positioned to manage costs in the years ahead.”

According to the survey, more than a quarter of insurers (27%) are predicting that mental health conditions will be among the three most common conditions affecting costs within the next five years, while 26% predict these conditions will be among the most expensive. Currently, cancer (83%), cardiovascular diseases (55%), and conditions affecting musculoskeletal and connective tissue (46%) are the top three conditions by cost and are expected to remain so in the near future. 

When asked for the most significant cost-driving factors outside the control of employers and vendors, seven in 10 respondents (70%) cited the high cost of medical technology, followed by providers’ profit motives (47%). Interestingly, nearly three in four insurers (73%) ranked overuse of care due to medical practitioners recommending too many services as the most significant factor driving costs related to employee and provider behavior. Two-thirds (66%) cited overuse of care due to employees seeking inappropriate care. Both figures represent an increase from 2019.

“The potential impact of mental health conditions is getting the attention of insurers and employers worldwide. As the demand for mental health services increases, employers can expect upward pressure on costs and challenges to existing health care models,” said Francis Coleman, managing director, Health and Benefits, Global Services and Solutions, Willis Towers Watson.

About the survey

The Willis Towers Watson 2020 Global Medical Trends Survey was conducted between July and September 2019 and reflects responses from 296 leading medical insurers operating in 79 countries.

About Willis Towers Watson

Willis Towers Watson (NASDAQ: WLTW) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has 45,000 employees serving more than 140 countries and markets. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.

Media contact

Ed Emerman:

EN
25/11/2019

Underlying

Reports on Willis Towers Watson Public Limited Company

 PRESS RELEASE

Willis Launches Global Digital Infrastructure Group to Address Full Sp...

Willis Launches Global Digital Infrastructure Group to Address Full Spectrum of Data Center Risks Team is uniquely equipped to provide holistic, customized advisory and risk transfer solutions tailored to the needs of the data center industry’s most sophisticated stakeholders NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Willis, a WTW business (NASDAQ: WTW), building on its newly , today announced the launch of its Global Digital Infrastructure Group led by Alastair Swift, Head of Willis Global Specialties. The group has been established to redefine and address the risks facing data cente...

 PRESS RELEASE

WTW appoints Han Wei Fong as new Country Leader for Singapore

WTW appoints Han Wei Fong as new Country Leader for Singapore SINGAPORE, Feb. 25, 2026 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today announced the appointment of Han Wei Fong as Country Leader for Singapore, effective 1 March 2026. Han Wei will hold dual capacity, continuing his current position as Head of Health & Benefits, Singapore, alongside his new country leadership responsibilities. Han Wei joined WTW in September last year and brings deep industry experience in health and benefits consulting and broking to WTW. He plays a ...

 PRESS RELEASE

WTW Announces Regular Quarterly Dividend

WTW Announces Regular Quarterly Dividend LONDON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, announced that its Board of Directors approved a regular quarterly cash dividend of $0.96 per common share for the quarter ended December 31, 2025. This represents a 4% increase to the prior quarter’s dividend. The dividend is payable on or about April 15, 2026 to shareholders of record at the close of business on March 31, 2026. About WTW At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people...

 PRESS RELEASE

Gray-zone aggression now a material threat for businesses, according t...

Gray-zone aggression now a material threat for businesses, according to new Willis report LONDON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Global stability is entering a new phase – one defined not by clear lines of conflict, but by the ambiguous, deniable and strategically choreographed tactics that sit between peace and war – known as ‘gray-zone aggression’. That’s the key finding of a new report from The Willis Research Network and Elisabeth Braw, a senior fellow with the Atlantic Council. Gray-zone aggression has rapidly evolved into a material threat for businesses; disrupting markets, und...

 PRESS RELEASE

Willis launches Reputational Risk Quantification Model for celebrity e...

Willis launches Reputational Risk Quantification Model for celebrity endorsement risk LONDON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Willis, a WTW business, (NASDAQ: WTW), today announced the launch of its for celebrity endorsement. Powered by rich datasets from Polecat, the model quantifies the reputational risk associated with celebrity endorsers and brand ambassadors. Celebrity endorser misconduct: a cross-sector reputational risk According to the Global Reputational Risk Readiness Survey 2024/25 99% of companies ranked reputation among their top 10 risks, with a significant proportion ra...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch